APAC IPOs & Placements

Zhen Zhou, Toh

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Ping An Healthcare and Technology / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/ping-an-healthcare-and-technology-company-limited" target="_blank" data-smartkarma-citation="entities:27008:1" rel="noopener">Ping An Healthcare and Technology Company Limited (1833 HK)</a> (PAGD) is looking to raise about US$1bn in its primary placement. The deal scored well on our framework owing to strong momentum from earnings and share price.We have previously covered the company's IPO and other online healthcare competitors in:<ul style="list-style-type: disc;">
<li>
<a href="https://www.smartkarma.com/insights/alibaba-health-placement-a-few-headwinds-but-multiple-tailwinds" target="_blank" data-smartkarma-citation="insights:41866" rel="noopener">Alibaba Health Placement - A Few Headwinds but Multiple Tailwinds</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/ping-an-good-doctor-what-can-we-expect-from-wedoctor" target="_blank" data-smartkarma-citation="insights:38560" rel="noopener">Ping An Good Doctor (平安好医生) - What Can We Expect from WeDoctor (微医)</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/wedoctor-pre-ipo-background-and-app-walk-through-the-online-medical-directory-and-more" target="_blank" data-smartkarma-citation="insights:37968" rel="noopener">WeDoctor (微医) Pre-IPO - Background and App Walk Through - The Online Medical Directory and More</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/wedoctor-pre-ipo-a-more-focused-online-medical-service-provider-than-ping-an-good-doctor" target="_blank" data-smartkarma-citation="insights:38472" rel="noopener">WeDoctor (微医) Pre-IPO - A More Focused Online Medical Service Provider than Ping An Good Doctor</a> </li>
</ul>

Ping An Healthcare and Technology Company Limited (1833 HK) (PAGD) is looking to raise about US$1bn in its primary placement. The deal scored well on our framework owing to strong momentum from earnings and share price.We have previously covered the company's IPO and other online healthcare competitors in:

Alibaba Health Placement - A Few Headwinds but Multiple Tailwinds 

Ping An Good Doctor (平安好医生) - What Can We Expect from WeDoctor (微医) 

WeDoctor (微医) Pre-IPO - Background and App Walk Through - The Online Medical Directory and More 

WeDoctor (微医) Pre-IPO - A More Focused Online Medical Service Provider than Ping An Good Doctor 


Ping An Good Doctor (平安好医生) - Accumulating Warchest for the Battles Ahead

JD Health International  / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/jd-health" target="_blank" data-smartkarma-citation="entities:29677:1" rel="noopener">JD Health (JDH HK)</a> is looking to raise about US$2bn in its upcoming Hong Kong IPO JDH’s retail pharmacy and online healthcare services form a strong, closed loop, end-to-end healthcare ecosystem that is well-positioned to benefit from the digitalization of China’s healthcare system. It has a strong network of online and offline pharmacies and it is expanding into offering more online healthcare services. Revenue has been strong in the past three years and it has accelerated further as a result of COVID-19. In this note, we will go through the company’s business, financials, operating metrics, and share our initial thoughts on the deal.

JD Health (JDH HK) is looking to raise about US$2bn in its upcoming Hong Kong IPO JDH’s retail pharmacy and online healthcare services form a strong, closed loop, end-to-end healthcare ecosystem that is well-positioned to benefit from the digitalization of China’s healthcare system. It has a strong network of online and offline pharmacies and it is expanding into offering more online healthcare services. Revenue has been strong in the past three years and it has accelerated further as a result of COVID-19. In this note, we will go through the company’s business, financials, operating metrics, and share our initial thoughts on the deal.

JD Health (京东健康) Pre-IPO - Well-Positioned to Ride China’s Healthcare Digitalization

China

JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

JD Health International (6618 HK)

Ping An Good Doctor (平安好医生) - Accumulating Warchest for the Battles Ahead

Ping An Healthcare and Technology Company Limited (1833 HK)

Zhen Zhou, Toh

JD Health (京东健康) Pre-IPO - Well-Positioned to Ride China’s Healthcare Digitalization

$jd healt is looking to raise about US$2bn in its upcoming Hong Kong IPO JDH’s retail pharmacy and online healthcare services form a strong,...

Zhen Zhou, Toh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)